MedPath

A study to compare ROPIVACAINE AND LEVOBUPIVACAINE ALONG WITH FENTANYL FOR LABOUR PAI

Not Applicable
Completed
Conditions
Health Condition 1: null- pregnant women with uncomplicated pregnancy, with no cpd
Registration Number
CTRI/2016/01/006544
Lead Sponsor
no
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Primigravida with singleton pregnancy

Willing to involve in this study

Categorized under ASA PS I & II

Exclusion Criteria

Patient refusal

High risk pregnancy

Primigravida with CPD

With fetal anomaly

Allergic to local anaesthetics

Injection site infection

Spine abnormalities

Significant coagulopathies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Onset of analgesia <br/ ><br>2.Duration of analgesia <br/ ><br>3.Quality of analgesia <br/ ><br>4.Degree of motor blockade <br/ ><br>Timepoint: 1.The onset of analgesia is -time from the first dose of epidural bolus to achieving Visual Analogue scale less than 3. <br/ ><br>2. Duration of analgesia-onset of analgesia to patient complaint visual analogue scale more than 3. <br/ ><br>15 min after adequate analgesia is achieved <br/ ><br>3. quality of analgesia will be assessed by verbal scoring system <br/ ><br>4.Presence of any motor blockade will be assessed using a Modified Bromage score
Secondary Outcome Measures
NameTimeMethod
1.Hemodynamic ( SpO2, MAP, PR, FHR) <br/ ><br>2.Foetal outcome <br/ ><br>3.Maternal satisfaction <br/ ><br>4.Side-effects <br/ ><br>Timepoint: 1.hemodynamics every ten minutes throughout the study <br/ ><br>2.APGAR Score at 2min and 5 min after baby delivery <br/ ><br>3.maternal satisfaction- at the end of the study <br/ ><br>4.side0effects throughout the study <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath